KinoPharma

About:

KinoPharma is a development-type bio-venture established to commercialize kinase inhibitors mainly for clinical application.

Website: https://www.kinopharma.com

Top Investors: Mitsubishi UFJ Capital, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Kyoto University Innovation Capital, Future Venture Capital, Japan Growth Investment Alliance

Description:

They are engaged in close research and development based on joint research contracts with universities, and they aim to develop clinical drugs with few side effects by utilizing know-how of phosphoenzyme inhibitor research. In addition, they are working on the development of therapeutic agents for intractable diseases such as viral diseases and neurodegenerative diseases, which target kinases.